A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate VeraCept®, a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy, Safety, and Tolerability.

Project: Research project

Status	Active
Effective start/end date	3/1/19 → 3/1/25

Project Details